Company News
Hunan Ouya Pharmaceutical Co., Ltd. is a high-tech enterprise integrating R&D, production, and marketing, is specialized in providing high-quality pharmaceutical APIs and intermediates. Driven by technological innovation, the company boasts a comprehensive quality management system and a modern production base that meets international standards. Its products are exported worldwidely, striving to become a trusted partner for global pharmaceutical companies.
The successful appearance of Ouya Pharma at the recently concluded Pharmedi 2025, held at SECC in Ho Chi Minh City, Vietnam, earned high recognition and praise from numerous new and existing customers and industry partners across Southeast Asia for its superior product quality, cutting-edge technological innovations, and professional market insights.
Under the theme "Innovation Drives, Building a Healthy Future," this year's Pharmedi Expo accurately responded to the growing demand for high-quality, cost-effective APIs in the pharmaceutical markets of Vietnam and Southeast Asia in the post-pandemic era. Ouya Pharma's booth (Booth: D22) consistently drew large crowds throughout the event, establishing itself as a key focal point for professional buyers at the scene.
At the exhibition, Ouya Pharma prominently showcased its core competitive advantages and innovative achievements:
? Star APIs Garnered Significant Attention: The company’s key products, such as Furosemide and Tetracaine, attracted a large number of visitors for in-depth discussions and inquiries. These products, with their consistent quality, comprehensive international certifications, and excellent cost-effectiveness, fully met the dual demands of Southeast Asia clients for supply chain reliability and product competitiveness.
? Integrated Customized Solutions Drew Interest: Beyond standard offerings, Ouya Pharma systematically introduced its one-stop customized solutions—from R&D support, process optimization to regulatory registration consulting for the first time in the Southeast Asia market. This initiative highlighted the company’s evolution from a “supplier” to a “partner,” demonstrating its ability to provide flexible and efficient collaborative support to the specific needs of local pharmaceutical companies.
The successful participation in Pharmedi not only strengthened our relationships with existing partners but also enabled us to establish connections with a wide range of potential new clients. We deeply felt the market’s trust and anticipation for high-quality APIs made in China. Moving forward, we will continue to increase our investment in the region, offering more innovative products and attentive services to grow together with our partners.
Through this exhibition, Ouya Pharma successfully secured multiple preliminary cooperation intentions and established direct contact with dozens of potential clients, laying a solid foundation for the company’s ongoing expansion into Southeast Asia market.
Search
